American Capital Management Inc. bought a new stake in shares of Medpace Holdings, Inc. (NASDAQ: MED

Medpace stock is back below a buy point of 628.92. The medical research contractor delivered an earn

Investors with an interest in Medical Services stocks have likely encountered both Concentra Group (

Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 10 years by 22.9% on an ann

The CEO sold 15,978 shares at a weighted-average price of $623.93 over two trading days ending Aug.

Bank of New York Mellon Corp bought a new stake in Medpace Holdings, Inc. (NASDAQ: MEDP) during the

B. Metzler seel. Sohn and Co. AG purchased a new stake in shares of Medpace Holdings, Inc. (NASDAQ:

Allworth Financial LP acquired a new stake in Medpace Holdings, Inc. (NASDAQ: MEDP) during the undef

Medpace (MEDP) reported earnings 30 days ago. What's next for the stock?

Abacus FCF Advisors LLC acquired a new stake in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) duri

Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.

Medpace Holdings, Inc. (NASDAQ: MEDP - Get Free Report) CEO August Troendle sold 11,366 shares of th

Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 14.56% on an ann

Investors interested in stocks from the Medical Services sector have probably already heard of Conce

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

NEW YORK, Aug. 10, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is inves

Medpace Holdings, Inc. (MEDP) reached a significant support level, and could be a good pick for inve

Medpace pairs double-digit growth, record awards and a strong balance sheet with a rich valuation, r

Medpace Holdings, Inc.  MEDP regained commercial momentum in the second quarter of 2026 as record aw

California State Teachers Retirement System lifted its position in Medpace Holdings, Inc. (NASDAQ: M

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

First Trust Advisors LP reduced its position in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) by 4

Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises th

BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and

Truist Securities analyst Jailendra Singh maintains Medpace Holdings (NASDAQ:MEDP) with a Hold an

RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and r

Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Neutral and raises th

Medpace says second-quarter earnings and revenue beat estimates, backed by stronger bookings, backlo

Stocks slide Thursday as Brent crude breaks $100 and the 10-year yield hits an 18-month high, while

Gainers NovoCure (NASDAQ:NVCR) shares moved upwards by 27.7% to $19.88 during Thursday's regula

On Thursday, Medpace Hldgs (NASDAQ:MEDP) discussed second-quarter financial results during its earni

U.S. stocks were down as Dow Jones fell 450 points on Thursday. Lockheed Martin (LMT) shares rose 11

Gainers Niki BioSolutions (NASDAQ:NIKI) stock moved upwards by 44.7% to $13.01 during Thursday'

Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares moved upwards by 24.0% to $1.71 during Wednesday

Medpace Holdings (NASDAQ:MEDP) raises FY2026 GAAP EPS guidance from $16.68-$17.50 to $17.25-$17.95 v

Medpace Hldgs (NASDAQ:MEDP) reported quarterly earnings of $4.25 per share which beat the analyst co

Companies Reporting Before The Bell • Northern Trust (NASDAQ:NTRS) is expected to report quarterly e

Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises th

Top Wall Street analysts changed outlook on top names, see all changes on analyst ratings page. HCA

Baird analyst Eric Coldwell downgrades Medpace Holdings (NASDAQ:MEDP) from Outperform to Neutral

Top Wall Street analysts changed outlook on some top names. Check all changes on analyst ratings pag

Jefferies analyst David Windley downgrades Medpace Holdings (NASDAQ:MEDP) from Buy to Hold and ra

A congressman ditches some Magnificent Seven stocks to buy some blue-chip, high dividend yield stock

Large-cap stocks slid sharply last week, pressured by earnings misses, weak guidance and analyst dow

Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and lo

BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and

RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and l

Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and lowers

Medpace stock drops despite Q1 beat as cancellations rise, bookings miss weighs on outlook and manag